Function, eligibility, outcomes, and exercise capacity associated with left ventricular assist devices: Exercise rehabilitation and training for patients with ventricular assist devices

Journal of Cardiopulmonary Rehabilitation

Volumn 23, Issue 3, 2003, Pages 208-217

  Kennedy, Michael D ^a   Haykowsky, Mark ^a   Humphrey, Reed ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b IDAHO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; HEPARIN; IMMUNOGLOBULIN; WARFARIN;

AORTA BALLOON; EQUIPMENT DESIGN; EXERCISE TOLERANCE; HEART ASSIST DEVICE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART REHABILITATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTATION; LUNG EMBOLISM; POSTOPERATIVE CARE; QUALITY OF LIFE; REVIEW; TRAINING; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EXERCISE TOLERANCE; HEART DISEASES; HEART-ASSIST DEVICES; HEMODYNAMIC PROCESSES; HUMANS; OXYGEN CONSUMPTION; PATIENT SELECTION; POSTOPERATIVE PERIOD;

EID: 0038281119     PISSN: 08839212     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008483-200305000-00009     Document Type: Review

References (60)

1. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med. 1998;339:1522-1533.
2. Myers TJ, Catanese KA, Vargo RL, Dressler DK. Extended cardiac support with a portable left ventricular assist system in the home. ASAIO J. 1996;42:M576-M579.
3. Nishimura M, Radovancevic B, Odegaard P, Myers T, Springer W, Frazier OH. Exercise capacity recovers slowly but fully in patients with a left ventricular assist device. ASAIO J. 1996;42:M568-M570.
4. Frazier OH, Macris MP, Myers TJ, et al. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg. 1994;57:1416-1422.
5. Helman DN, Rose EA. History of mechanical circulatory support. Prog Cardiovasc Dis. 2000;43:1-4.
6. Takano H, Nakatani T, Taenaka Y, et al. Treatment of acute profound heart failure by ventricular assist device. Jpn Circ J. 1992;56:100-110.
7. Hunt SA, Frazier OH. Mechanical circulatory support and cardiac transplantation. Circulation. 1998;97:2079-2090
8. Portner PM, Oyer PE, Pennington DG, et al. Implantable electrical left ventricular assist system: bridge to transplantation and the future. Ann Thorac Surg. 1989;47:142-150.
9. Bank AJ, Mir SH, Nguyen DQ, et al. Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. Ann Thorac Surg. 2000;69:1369-1374.
10. McCarthy PM, Hoercher K. Clinically available intracorporeal left ventricular assist devices. Prog Cardiovasc Dis. 2000;43:37-46.
11. Dowling RD, Etoch SW. Clinically available extracorporeal assist devices. Prog Cardiovasc Dis 2000;43:27-36.
12. Farrar DJ, Holman WR, McBride LR, et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant. 2002;21:516-521.
13. Zareba KM. The artificial heart: past, present, and future. Med Sci Monit. 2002;8:RA72-RA77.
14. Lowe JE, Anstadt MP, Van Trigt P, et al. First successful bridge to cardiac transplantation using direct mechanical ventricular actuation. Ann Thorac Surg. 1991;52:1237-1243.
15. Frazier OH, Myers TJ, Gregoric ID, et al. Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation. 2002;105:2855-2860.
16. Maher TR, Butler KC, Poirier VL, Gernes DB. HeartMate left ventricular assist devices: a multigeneration of implanted blood pumps. Artif Organs. 2001;25:422-426.
17. Novacor LVAS. Available at: www.worldheart.com. Accessed: October 12, 2002.
18. Heartmate Overview. Available at: www.thermocardio.com. Accessed: November 25, 2000.
19. Humphrey R. Exercise physiology in patients with left ventricular assist devices. J Cardiopulm Rebabil. 1997;17:73-75.
20. Deng MC, Wilhelm M, Weyand M, et al. Long-term left ventricular assist device support: a novel pump rate challenge exercise protocol to monitor native left ventricular function. J Heart Lung Transplant. 1997;16:629-635.
21. Humphrey R, Buck LA, Cahalin LP, Morrone TM. Physical therapy assessment and intervention for patients with left ventricular assist devices. Cardiopulm Phys Ther. 1998;9:3-7.
22. Clark RE, Zafirelis Z. Future devices and directions. Prog Cardiovasc Dis. 2000;43:95-100.
23. Adamson RM, Dembitsky WP, Jaski BE, et al. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency. ASAIO J. 1997;43:365-369.
24. McCarthy PM, Smedira NG. Implantable LVAD insertion in patients with previous heart surgery. J Heart Lung Transplant. 2000;19(suppl 8):S95-S100.
25. Helman DN, Addonizio LJ, Morales DL, et al. Implantable left ventricular assist devices can successfully bridge adolescent patients to transplant. J Heart Lung Transplant. 2000;19:121-126.
26. Emery RW, Eales F, Joyce LD, et al. Mechanical circulatory assistance after heart transplantation. Ann Thorac Surg. 1991;51:43-47.
27. Dyke DB, Pagani FD, Aaronson KD. Circulatory assist devices 2000: an update. Congest Heart Fail. 2000;6:259-271.
28. El-Banayosy A, Arusoglu L, Kizner L, et al. Predictors of survival in patients bridged to transplantation with the Thoratec VAD device: a single-center retrospective study on more than 100 patients. J Heart Lung Transplant. 2000;19:964-968.
29. Deng MC, Weyand M, Hammel D, et al. Selection and management of ventricular assist device patients: the Muenster experience. J Heart Lung Transplant. 2000;19(suppl 8):S77-S82.
30. Jaski BE, Lingle RJ, Kim J, et al. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial. J Heart Lung Transplant. 1999;18:1031-1040.
31. Mancini D, Goldsmith R, Levin H, et al. Comparison of exercise performance in patients with chronic severe heart failure versus left ventricular assist devices. Circulation. 1998;98:1178-1183.
32. Tagusari O, Kormos RL, Kawai A, et al. Native heart complications after heterotopic heart transplantation: insight into the potential risk of left ventricular assist device. J Heart Lung Transplant. 1999;18:1111-1119.
33. Heath MJ, Dickstein ML. Perioperative management of the left ventricular assist device recipient. Prog Cardiovasc Dis. 2000;43:47-54.
34. Oz MC, Rose EA, Levin HR. Selection criteria for placement of left ventricular assist devices. Am Heart J. 1995;129:173-177.
35. Kavarana MN, Pessin-Minsley MS, Urtecho J, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg. 2002;73:745-750.
36. Arabia FA, Smith RG, Rose DS, Arzouman DA, Sethi GK, Copeland JG. Success rates of long-term circulatory assist devices used currently for bridge to heart transplantation. ASAIO J. 1996;42:M542-M546.
37. Jaski BE, Lingle RJ, Reardon LC, Dembitsky WP. Left ventricular assist device as a bridge to patient and myocardial recovery. Prog Cardiovasc Dis. 2000;43:5-18.
38. Levin HR, Chen JM, Oz MC, et al. Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg. 1994;58:1515-1520.
39. Khan T, Levin HR, Oz MC, Katz SD. Delayed reversal of impaired metabolic vasodilation in patients with end-stage heart failure during long-term circulatory support with a left ventricular assist device. J Heart Lung Transplant. 1997;16:449-453.
40. Baldwin RT, Duncan JM, Radovancevic B, Frazier OH, Abou-Awdi NL. Recovery of pulmonary function in patients undergoing extended left ventricular assistance. Chest. 1992;102:45-49.
41. Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation. 1995;91:2717-2720.
42. Morales DL, Argenziano M, Oz MC. Outpatient left ventricular assist device support: a safe and economical therapeutic option for heart failure. Prog Cardiovasc Dis. 2000;43:55-66.
43. Grady KL, Meyer P, Mattea A, et al. Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation. J Heart Lung Transplant. 2001;20:657-669.
44. Itescu S, Ankersmit JH, Kocher AA, Schuster MD. Immunobiology of left ventricular assist devices. Prog Cardiovasc Dis. 2000;43:67-80.
45. Morrone TM, Buck LA, Catanese KA, et al. Early progressive mobilization of patients with left ventricular assist devices is safe and optimizes recovery before heart transplantation. J Heart Lung Transplant. 1996;15:423-429.
46. de Jonge N, Kirkels H, Lahpor JR, et al. Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation: an outlook for permanent assisting? J Am Coll Cardiol. 2001;37:1794-1799.
47. Foray A, Williams D, Reemtsma K, Oz M, Mancini D. Assessment of submaximal exercise capacity in patients with left ventricular assist devices. Circulation. 1996;94(suppl 9):II222-II226.
48. Jaski BE, Kim J, Maly RS, et al. Effects of exercise during long-term support with a left ventricular assist device: results of the experience with left ventricular assist device with exercise (EVADE) pilot trial. Circulation. 1997;95:2401-2406.
49. Frazier OH, Benedict CR, Radovancevic B, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 1996;62:675-681.
50. Buck LA. Physical therapy management of three patients following left ventricular assist device implantation: a case report. Cardiopulm Phys Ther. 1998;9:8-14.
51. Humphrey R, Manetz C, Tolman DE, et al. Exercise training responses in a patient with a left ventricular assist device [abstract]. J Cardiopulm Rehabil. 1996;16:310.
52. Buck LA, Morrone TM, Goldsmith R, Humphrey R, Manetz C, Cahalin LP. Exercise training of patients with left ventricular assist devices: a pilot study of physiologic adaptations [abstract]. J Cardiopulm Rehabil. 1996;16:324.
53. Mettauer B, Geny B, Lonsdorfer-Wolf E, et al. Exercise training with a heart device: a hemodynamic, metabolic, and hormonal study. Med Sci Sports Exerc. 2001;33:2-8.
54. 2002 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2001.
55. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
56. Westaby S, Banning AP, Saito S, et al. Circulatory support for long-term treatment of heart failure: experience with an intraventricular continuous flow pump. Circulation. 2002;105:2588-2591.
57. Pagani FD, Lynch W, Swaniker K et al. Extracorporeal life support to left ventricular assist device bridge to heart transplant: a strategy to optimize survival and resource utilization. Circulation. 1999;100(suppl 19):II206-II210.
58. Pavie A, Leger P, Regan M, et al. Emergency mechanical circulatory support: still viable? J Heart Lung Transplant. 2000;19(suppl 8):S101-S104.
59. Gronda E, Mangiavacchi M, Frigerio M, et al. Determination of candidacy for mechanical circulatory support: importance of clinical indices. J Heart Lung Transplant. 2000;19(suppl 8):S83-S88.
60. Branch KR, Dembitsky WP, Peterson KL, et al. Physiology of the native heart and Thermo Cardiosystems left ventricular assist device complex at rest and during exercise: implications for chronic support. J Heart Lung Transplant. 1994;13:641-650.